Table 2. Comparison of concordance of CR and self-reporting of breast, bowel or lung cancer between 1995 and 2007 in survivors vs deceased.
|
CR for relevant cancer not available |
CR |
|
|||
---|---|---|---|---|---|---|
No. of women | No. of women | No. of women | % | 95% CI | P-value | |
Self-reported breast cancer | ||||||
Breast cancer primary or contributory cause of deatha | 333 | 4 | 329 | 98.8 | 96.9–99.7% | 0.001 |
Survivors in cohort |
4704 |
260 |
4444 |
94.5 |
93.8–95.1% |
|
Self-reported bowel cancer | ||||||
Bowel cancer primary or contributing cause of deathb,c | 37 | 2 | 35 | 94.6 | 81.8–99.3% | 0.106 |
Survivors in cohort |
545 |
80 |
465 |
85.3 |
82.1–88.2% |
|
Self-reported lung cancer | ||||||
Lung cancer primary or contributing cause of death | 21 | 2 | 19 | 90.5 | 69.6–98.2% | 0.681 |
Survivors in cohort | 62 | 8 | 54 | 87.1 | 76.1–94.3% |
Abbreviations: CR=cancer registration, includes in situ carcinomas of the breast and bowel; CI=confidence interval.
Excluded 173 women who died from causes unrelated to breast cancer.
Excluded 26 women who died from causes unrelated to bowel cancer.
Includes C17 and C21.